home / stock / gbs / gbs news


GBS News and Press, GBS Inc. From 06/11/21

Stock Information

Company Name: GBS Inc.
Stock Symbol: GBS
Market: NASDAQ

Menu

GBS GBS Quote GBS Short GBS News GBS Articles GBS Message Board
Get GBS Alerts

News, Short Squeeze, Breakout and More Instantly...

GBS - Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Good morning, investors! We’re approaching the end of trading for the week but we’ve got one more day of market coverage to bring you. Of course, we’re starting that off with a look at the biggest pre-m...

GBS - Aethlon Medical, Checkpoint Therapeutics leads healthcare gainers; Atossa Therapeutics, CEL-SCI among major losers

Gainers: Aethlon Medical AEMD +425%, Checkpoint Therapeutics CKPT +26%, Adamis Pharmaceuticals ADMP +12%, SCWorx (WORX) +18%, ZIOPHARM Oncology ZIOP +15%.Losers: Atossa Therapeutics ATOS -14%, CEL-SCI CVM -11%, Precipio (PR...

GBS - Clover Health Investments, Precipio leads healthcare gainers; Ra Medical Systems, HOOKIPA Pharma among major losers

Gainers: Clover Health Investments CLOV +70%, Precipio PRPO +15%, GBS (GBS) +15%, PDS Biotechnology PDSB +15%, Cyclerion Therapeutics CYCN +10%.Losers: Ra Medical Systems RMED -19%, HOOKIPA Pharma HOOK -15%, AC Immune (ACIU...

GBS - Patients Living With Diabetes Voice Eagerness for 'Finger-Prick' Alternative in Global Glucose Monitoring Survey

NEW YORK, June 08, 2021 (GLOBE NEWSWIRE) -- GBS Inc. (Nasdaq: GBS), a life sciences company developing non-invasive, real-time diagnostic testing for patients and their primary health practitioners at point-of-care, today announced survey results from more than 300 patients globally as part...

GBS - GBS reports Q1 results

GBS (GBS): Q1 GAAP EPS of -$0.27.Cash, cash equivalents, and marketable securities of $14.2M.Press Release For further details see: GBS reports Q1 results

GBS - GBS Inc. Reports First Quarter 2021 Financial Results and Recent Business Highlights

- Anticipate Emergency Use Submission for SARS-CoV-2 Antibody Biosensor Test in the Second Half of 2021- - $14 Million in Cash, Cash Equivalents, and Marketable Securities as of March 31, 2021, Provides Runway into the Second Half of 2022 - - Established a Point-of-C...

GBS - ATVI, TEVA, AYX and LYFT among notable premarket gainers

Chiasma (CHMA) +39% on Q1 results.Athenex (ATNX) +31% on Kuur Therapeutics acquisition.Ault Global Holdings (DPW) +30% on preliminary Q1 results.iBio (IBIO) +26% after resolving Fraunhofer USA lawsuitBig 5 Sporting Goods Corporation (BGFV) +22% on Q1 results.DAVIDsTEA...

GBS - The Mosaic, Ballard Power Systems among premarket losers' pack

Image Sensing Systems (ISNS) -26% on Q1 earnings release.Regional Health Properties (RHE) -21%.Brooklyn ImmunoTherapeutics (BTX) -20%.Ballard Power Systems (BLDP) -13% on Q1 earnings release.SunLink Health Systems (SSY) -10%.Ocugen (OCGN) -11%.iRobot (IRBT) -10% ...

GBS - Shares of GBS Inc. (GBS) Surpass 52-Week Low

GBS Inc. (NASDAQ:GBS) traded today at a new 52-week low of $4.23. This new low was reached on above average trading volume as 622,000 shares traded hands, while the average 30-day volume is approximately 121,000 shares. GBS Inc. share prices have moved between a 52-week high of $14.24 an...

GBS - GBS Inc. Looks to Continue to Trade Below its Annual-Low Share Price Today

GBS Inc. (NASDAQ:GBS) traded today at a new 52-week low of $4.16. So far today approximately 622,000 shares have been exchanged, as compared to an average 30-day volume of 247,000 shares. GBS Inc. share prices have moved between a 52-week high of $14.24 and the current low of $4.16 and a...

Previous 10 Next 10